Picture of Global Innovative Platforms logo

GIPL Global Innovative Platforms Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+383.75%
3m+928.96%
6m+902.65%
1yr+827.27%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value291.77
Price to Tang. Book291.77
Price to Free Cashflown/a
Price to Salesn/a
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-154.63%
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Sep 202530th Sep 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Global Innovative Platforms EPS forecast chart

Profile Summary

Global Innovative Platforms Inc. is focused on advancing animal health through breath analysis and air quality technology. The Company develops non-invasive diagnostic tools for detecting diseases, assessing treatment effectiveness, and monitoring potentially toxic environmental and food conditions. Its proprietary technologies, VOCAM Plus and the FROG, utilize advanced gas chromatography and artificial intelligence (AI) software to provide rapid breath and air analysis. VOCAM technology consists of two components: one which it is developing to collect the samples, and a second component to process and analyze breath samples that indicate multiple volatile organic compounds (VOC) on a single reading to measure a variety of potential threats, including its initial focus on the heartworm market. FROG utilizes similar technology as the VOCAM Plus, but it also includes a collection wand, to collect samples, eliminating the need for an external water, soil, feed, or air collection device.

Directors

Last Annual
September 30th, 2024
Last Interim
December 31st, 2024
Incorporated
September 15th, 2020
Public Since
December 23rd, 2003
No. of Shareholders
170
No. of Employees
52
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
39,111,241
Blurred out image of a map
Address
149 James Place, MAITLAND, 32751
Web
Phone
+1 3212303739
Auditors
M.S. Madhava Rao

GIPL Share Price Performance

Similar to GIPL

Picture of Aamaxan Transport logo

Aamaxan Transport

us flag iconPink Sheets on Nasdaq

Picture of ACCUSTEM SCIENCES logo

ACCUSTEM SCIENCES

us flag iconPink Sheets on Nasdaq

Picture of Acutus Medical logo

Acutus Medical

us flag iconPink Sheets on Nasdaq

Picture of ADM Tronics Unlimited logo

ADM Tronics Unlimited

us flag iconPink Sheets on Nasdaq

FAQ